MetaCap

Elevance Health Inc. (ELV)

NYSE: ELVHealth CareMedical SpecialitiesUSD

394.48+4.32 (+1.11%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ELV stock chart

Technical analysis

Key statistics

All statistics
Market cap
$85.23B
EPS (TTM)
$23.55
Dividend yield
1.74% ($6.87)
Ex-dividend date
Sep 10, 2026
52-week range
274.84 – 450.69
Day range
393.55 – 406.36
Volume / Avg
2.04M / 1.31M
Beta
—

52-week range

$274.84$450.69

ELV stock today

Shares of Elevance Health (ELV) finished higher on Nov 20 at $394.48, a gain of 1.11% or $4.32 per share, versus the S&P 500's 3.70% decline. Shares are 12.5% below their 52-week high of $450.69, set on Oct 21, 2026 and 43.5% above the 52-week low of $274.84, in the middle of the past year's range. ELV is up 12.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 22.6%.

At 16.8x trailing earnings, Elevance Health trades below the peer-group median of 27.9x. Its forward P/E of 13.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Elevance Health pays an annual dividend of $6.87 per share, a 1.74% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Elevance Health

Company profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits.

Industry
Medical Specialities
CEO
Ms. Gail Koziara Boudreaux
Headquarters
Indianapolis, IN
Employees
96,129

Financial highlights

Full financials

In fiscal 2025, Elevance Health generated $199.13 billion in revenue, up 12.5% from fiscal 2024, its 15th consecutive year of revenue growth. Net income was $5.66 billion (-5.3% year over year), for a net margin of 2.8% versus a median of 3.8% in the prior 5 years. Gross margin was 89.4% (up from 88.8%) and operating margin 3.6%.

Elevance Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$199.13B$177.01B$171.34B$156.59B$138.64B
Growth+12.49%+3.31%+9.42%+12.95%+13.76%
Net income$5.66B$5.98B$5.99B$5.89B$6.16B
EPS (diluted)$25.21$25.68$25.22$24.28$24.95

Analyst forecast

Forecast

Consensus (22 analysts)

buy

Avg. price target

$482.38+22.28%

  • Strong buy 3
  • Buy 12
  • Hold 7
  • Sell 0
  • Strong sell 0

Target range

Low $406.00High $523.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 21, 2026
EPS actual vs est.
$6.27 vs $4.66
Surprise
+34.55%

Dividends

Dividend history
Annual dividend
$6.87
Last payment
$1.72
Ex-dividend date
Sep 10, 2026

ELV news

All ELV news

Elevance Health peers

Health Care sector
ELV peer companies
CompanyPrice% ChgMarket capCompare
CIThe Cigna Group270.90-0.78%$71.38Bvs ELV
HUMHumana Inc.390.00+2.63%$46.84Bvs ELV
NTRANatera Inc.273.40-5.70%$39.64Bvs ELV
CNCCentene Corporation63.78-2.74%$31.58Bvs ELV
LHLabcorp Holdings Inc.367.13-0.47%$29.81Bvs ELV
ILMNIllumina Inc.192.82-3.90%$29.15Bvs ELV
DGXQuest Diagnostics Incorporated258.28-0.31%$28.42Bvs ELV
GHGuardant Health Inc.145.83+0.16%$19.73Bvs ELV

Indexes, lists and sector

Elevance Health stock FAQ

What is Elevance Health's stock price today?

ELV last traded at $394.48 as of Nov 20, 4:00 PM EST, up 1.11% on the day. Prices are delayed at least 15 minutes.

Does Elevance Health pay a dividend?

Yes. Elevance Health pays $6.87 per share annually, a 1.74% yield. The most recent dividend of $1.72 had an ex-dividend date of Sep 10, 2026.

What is ELV's P/E ratio?

ELV trades at a trailing P/E ratio of 16.75 and a forward P/E of 13.02, compared with a median of 27.9 for its closest peers.

Is Elevance Health in the S&P 500?

Yes. Elevance Health (ELV) is a constituent of the S&P 500 index.

Who is Elevance Health's CEO?

Ms. Gail Koziara Boudreaux is the chief executive officer of Elevance Health Inc., which has about 96,129 employees.

Has ELV ever split its stock?

Yes. The most recent ELV stock split was a 2-for-1 split on Jun 1, 2005.

What is the ELV 52-week high?

The 52-week high for ELV is $450.69 and the 52-week low is $274.84. The stock is currently 12.5% below its high.

Compare ELV